Warner-lambert Company

Prosidion Limited

Pfizer Corporation

Other

Osi Pharmaceuticals, Inc.

Pfizer Products Inc.

Martin James Procter

Karen Lesley Schofield

Stuart Edward Bradley

Matthew Colin Thor Fyfe

Eric W Collington

Vilasben Kanji Shah

Geoffrey Martyn Williams

Daniel Y Du

Matthew C Fyfe

Thomas Martin Krulle

Chrystelle Marie Rasamison

Gerard Hugh Thomas

Lisa Sarah Gardner

Colin P Sambrook Smith

Joanna Victoria Geden

Kosuke Yasuda

William Thomas Gattrell

Robert John Rowley

Maseo Nawano

Colin Peter Sambrook Smith

Jonathan G Williams

Jason Bloxham

Robert J Rowley

Peter J Murray

Peter John Murray

Donald Smyth

Colin Peter Sambrook-Smith

Andrew Francis Browning

David James Witter

Arlindo Lucas Castelhano

Lisa Sarah Bertram

Tom Banksia Dupree

Alan John Stewart

Revathy Perpetua Jeevaratnam

Peter Timothy Fry

Ana Valdesabril

Patrick Eric Hanrahan

John King-Underwood

Ana Valdes

Peter John c/o Patents Department Murray

Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity. 

Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders

Compounds of Formula (I), R-A-V&#x2014;B&#x2014;R; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.

Heterocyclic derivatives as GPCR receptor agonists

Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase

Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity. 

Bicyclic aryl and heteroaryl receptor modulators

Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth. 

Pyrrolopyridine-2-carboxylic acid hydrazides

Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Tri(cyclo) substituted amide compounds

The present invention is directed to 4-cyclopentyl resorcinol monohydrate, its Form I polymorph, formulations containing at least one of these compounds, and their use to lighten skin.

Depigmentation agents

The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.

Resorcinol derivatives

Compounds of Formula (I): or pharmaceutically acceptable salts or N-oxides thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Tri(cyclo) substituted amide glucokinase activator compounds

The present invention is directed to a new class of 6-benzyl urea/thiourea-quinolin-2-one derivatives and 2-oxo-6-benzylurea/thiourea-chromene derivatives. These compound are androgen antagonists and are useful in the treatment of alopecia, acne and other conditions associated with inappropriate activation of the androgen receptor.

Benzyl urea and thiourea derivatives

The present invention is directed to a new class of 6-benzylsulfonamido-quinoline/chromene derivatives, to their use as androgen antagonists, and to formulations containing these androgen antagonists.

Benzyl sulfonamide derivatives

The invention is directed to a new class of quinolin-zene and z-exc chromen compounds that have been derivatized at the 6-position with a urea or this urea moet, and to then use as androgen antagonists.

Urea and thiourea derivatives

Growing community of inventors

Oxford, United Kingdom

Martin James Procter